Tempus AI reported its second-quarter 2025 financial results, with quarterly revenue reaching $314.64 million, an increase of 89.6% year-over-year. Genomics revenue contributed $241.8 million, growing 115.3% year-over-year, while Data and Services revenue was $72.8 million, up 36.8% year-over-year.
The company reported a net loss of $(42.8 million) for the quarter, with an adjusted loss of $(0.22) per share, which beat analyst estimates of $(0.24) per share. This indicates improved financial performance and progress towards profitability.
Tempus AI raised its full-year 2025 revenue guidance to approximately $1.25 billion and reaffirmed its Adjusted EBITDA guidance of $5 million for the full year. Additionally, the company announced a $500 million equity offering, reflecting confidence in its growth prospects and a strategic move to secure capital for future investments.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.